Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2021–2025 · award
Defining Evolutionary Trajectories Driving Prostate Cancer Metastases
2021–2025 · award
Regulation of Collective Breast Cancer Invasion and Metastasis
Stephanie Fraley
2021–2026 · award
Optimizing care delivery and health equity in patients with melanoma
2021–2025 · award
Exposures from oil and gas development and childhood leukemia risk
Lisa Mckenzie · University Of Colorado Denver, Amc And Dc
2021–2022 · award
Understanding the impact of COVID-19 on cervical cancer screening and management of abnormal results in underserved women
2021–2022 · award
Can aneuploidy drive resistance to BRAFi/MEKi therapy in melanoma?
2021–2025 · award
Nutrient Insufficiency and Peripheral Neuropathy Risk-Second Resubmission
2021–2024 · award
Epigenetic regulation of breast tumor initiation
Weibo Luo · The University Of Texas Southwestern Medical Center (ut Southwestern)
2021–2025 · award
Integrated transcriptome-based prognostic and disease monitoring strategies in childhood AML
2021–2022 · award
Can aneuploidy drive resistance to BRAFi/MEKi therapy in melanoma?
2021–2024 · award
Building a sustainable intervention to improve endocrine therapy adherence
2021–2026 · award
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
2021–2024 · award
The therapeutic role of lncRNA- mediated DNA repair in lung cancer
Crystal Marconett · University Of Southern California (usc)
2021–2024 · award
Combined Targeting of Aurora Kinase and Bcl-2 in Double-Hit Lymphoma
Steven Park · Atrium Health Foundation
2021–2025 · award
Defining Protein Lysine Acetylation Mechanisms During DNA Replication
2021–2025 · award
HNF4a regulates pancreatic cancer growth, metabolism and molecular subtype
2021–2025 · award
Determinants of Disparities in Post-Surgical Outcomes in GI Malignancies
2021–2025 · award
Neutralizing the effects of aging to enhance brain cancer immunotherapy
2021–2024 · award
The Role of Neutrophil-Derived Nucleoprotein in Tumor Growth and Metastasis
2021–2022 · award
Targeting USP9X-mediated RIT1 stabilization for cancer therapy
2021–2025 · award
Control of post-mitotic genome reactivation by transcription elongation
Leighton Core · University of Connecticut
2021–2023 · award
Cytochrome c-deficiency in African American men with prostate cancer
2021–2025 · award
Mechanisms and Regulation of DNA break processing in eukaryotes
2020–2024 · award
Eradication of Metastatic GRP78+ Breast Cancer Cells Using Nanotherapeutics
2020–2024 · award
Stromal niche as regulators of breast cancer metastasis
2020–2022 · award
Cultural Adaptation of Meaning-Centered Psychotherapy for Latino families
Normarie Torres-Blasco · Ponce Health Sciences University
2020–2022 · award
Defining Enhancer RNA Function in the Pathogenesis of Breast Cancer
Michael Lewis · University of North Carolina at Chapel Hill
2020–2024 · award
Hollings Cancer Center American Cancer Society Insitutional Research Grant
2020–2024 · award
Sleep disordered breathing as a targetable risk factor in multiple myeloma
2020–2025 · award
Ensuring the delivery of high quality care for patients with cancer
2020–2024 · award
Clinical Research Professor
Wendy Demark-Wahnefried · University of Alabama at Birmingham
2020–2022 · award
Role of human Pumilio proteins in Acute Myeloid Leukemia
2020–2024 · award
Overcoming Resistance and Heterogeneity in FGFR2+ Cholangiocarcinoma
Lipika Goyal · The Board Of Trustees Of The Leland Stanford Junior University
2020–2024 · award
Targeting CD47 prevents cancer therapy adverse effects
2020–2024 · award
Developing Novel Therapeutics for Aggressive Variants of CTCL
2020 · award
Targeting DNA repair defects induced by immune signaling in non-small cell lung cancer
2020–2024 · award
Perturbing the evolutionary drivers of targeted therapy resistance in NSCLC
2020 · award
A Systems Basis for KRAS Mutant Specific Responses to Targeted Therapy
2020–2024 · award
Gaps in genetic risk prevention in breast cancer patients and their family
2020–2022 · award